What is it about?
The aim of this study is to determine the association of serum insulin-like growth factor 1 (IGF-1) and vitamin D levels with cognition status in patients with type 2 diabetes mellitus (T2DM). We find that low serum IGF-1 and 25(OH)D levels may separately predict poor cognitive performance in patients with diabetes.
Featured Image
Photo by Sharon McCutcheon on Unsplash
Why is it important?
This study preliminary revealed the associations between IGF-1 and vitamin D on MCI in patients with diabetes. This study suggested that both serum IGF-1 and 25(OH)D can be serological markers of mild cognitive impairment of diabetes.
Perspectives
This study suggested that both serum IGF-1 and 25(OH)D can be serological markers of mild cognitive impairment of diabetes.
yongde peng
Read the Original
This page is a summary of: Decreased Levels of Serum IGF-1 and Vitamin D Are Associated With Cognitive Impairment in Patients With Type 2 Diabetes, American Journal of Alzheimer s Disease & Other Dementias®, July 2019, SAGE Publications, DOI: 10.1177/1533317519860334.
You can read the full text:
Resources
Contributors
The following have contributed to this page
